Skip to main content

Main menu

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN

User menu

Search

  • Advanced search
CMAJ
  • CMAJ JOURNALS
    • CMAJ Open
    • CJS
    • JAMC
    • JPN
CMAJ

Advanced Search

  • Home
  • Content
    • Current issue
    • Past issues
    • Early releases
    • Collections
    • Sections
    • Blog
    • Infographics & illustrations
    • Podcasts
    • COVID-19 Articles
  • Authors & Reviewers
    • Overview for authors
    • Submission guidelines
    • Submit a manuscript
    • Forms
    • Editorial process
    • Editorial policies
    • Peer review process
    • Publication fees
    • Reprint requests
    • Open access
    • Patient engagement
  • Members & Subscribers
    • Benefits for CMA Members
    • CPD Credits for Members
    • Subscribe to CMAJ Print
    • Subscription Prices
  • Alerts
    • Email alerts
    • RSS
  • JAMC
    • À propos
    • Numéro en cours
    • Archives
    • Sections
    • Abonnement
    • Alertes
    • Trousse média 2023
  • Visit CMAJ on Facebook
  • Follow CMAJ on Twitter
  • Follow CMAJ on Pinterest
  • Follow CMAJ on Youtube
  • Follow CMAJ on Instagram
Practice

Managing anticoagulation and antiplatelet therapy before interventional radiology procedures

Mark O. Baerlocher, Andy Myers and Murray Asch
CMAJ February 08, 2011 183 (2) 223; DOI: https://doi.org/10.1503/cmaj.090586
Mark O. Baerlocher
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Andy Myers
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray Asch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF
Loading

Patients taking antiplatelet or anticoagulation agents require blood tests before any non-emergent interventional radiology procedure

Before any interventional radiology procedure, including biopsy and abscess drainage, patients should have testing to determine the complete blood count (including platelet count), activated partial thromboplastin time and international normalized ratio.1 The tests should be done as close to the time of the procedure as possible. For stable patients, the timing of blood tests should be within one week of the procedure, in general.

Antiplatelet and anticoagulation therapy should be temporarily stopped, if possible, to achieve optimal coagulation before the procedure

The risk of secondary bleeding from the procedure must be weighed against the risk of complications because of cessation of anticoagulation.2 Discussion of risks with a relevant consultant and the treating radiologist may be warranted. Care must be taken in withholding medications in patients taking acetylsalicylic acid for secondary prevention following coronary stenting or a stroke.3

An inability or insufficient time to reverse the patient’s anticoagulation status does not necessarily preclude the procedure

In this situation, discussion with the treating radiologist is warranted. Reversal agents may be required to ensure patient safety; these include vitamin K for warfarin; protamine sulfate for heparin; fresh frozen plasma or platelet transfusion; cryoprecipitate in acquired or congenital fibrinogen deficiency; recombinant factor VIIa; and desmopressin.2,4

Some published data suggest that reversal may not be necessary in patients with liver disease and mild coagulopathy.5

Recommendations for temporarily stopping specific anticoagulation and antiplatelet agents vary

Suggested time frames for temporary discontinuation of specific medications are outlined in Appendix 1 (www.cmaj.ca/cgi/content/full/cmaj.090586/DC1). Temporary discontinuation of acetyl-salicylic acid and nonsteroidal anti-inflammatory drugs may not be necessary for some procedures of lower or moderate risk, and individual practice may vary.1

Some patients receiving long-term anticoagulation (e.g., those with prosthetic heart valves or within three months of acute venous thromboembolism) may require “bridging” anticoagulation with heparin or low-molecular-weight heparin.

A lack of evidence contributes to variation in clinical practice

The variation in clinical practice is due in part to a lack of evidence from randomized controlled trials. Data from open surgical procedures may not apply to interventional radiology procedures, because those procedures involve open, direct visualization of any bleeding sources that occur.4 The individual patient’s comorbidities and prior history of bleeding, as well as the specific interventional radiology procedure to be performed and associated “bleeding risk,” will influence the preparations needed. In cases where the referring clinician is unsure, consultation with the treating radiologist is recommended.

Footnotes

  • Competing interests: None declared.

  • This article has been peer reviewed.

  • For references, please see Appendix 2, available at www.cmaj.ca/cgi/content/full/cmaj.090586/DC1

PreviousNext
Back to top

In this issue

Canadian Medical Association Journal: 183 (2)
CMAJ
Vol. 183, Issue 2
8 Feb 2011
  • Table of Contents
  • Index by author

Article tools

Respond to this article
Print
Download PDF
Article Alerts
To sign up for email alerts or to access your current email alerts, enter your email address below:
Email Article

Thank you for your interest in spreading the word on CMAJ.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Managing anticoagulation and antiplatelet therapy before interventional radiology procedures
(Your Name) has sent you a message from CMAJ
(Your Name) thought you would like to see the CMAJ web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Managing anticoagulation and antiplatelet therapy before interventional radiology procedures
Mark O. Baerlocher, Andy Myers, Murray Asch
CMAJ Feb 2011, 183 (2) 223; DOI: 10.1503/cmaj.090586

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
‍ Request Permissions
Share
Managing anticoagulation and antiplatelet therapy before interventional radiology procedures
Mark O. Baerlocher, Andy Myers, Murray Asch
CMAJ Feb 2011, 183 (2) 223; DOI: 10.1503/cmaj.090586
Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like

Jump to section

  • Article
    • Patients taking antiplatelet or anticoagulation agents require blood tests before any non-emergent interventional radiology procedure
    • Antiplatelet and anticoagulation therapy should be temporarily stopped, if possible, to achieve optimal coagulation before the procedure
    • An inability or insufficient time to reverse the patient’s anticoagulation status does not necessarily preclude the procedure
    • Recommendations for temporarily stopping specific anticoagulation and antiplatelet agents vary
    • A lack of evidence contributes to variation in clinical practice
    • Footnotes
  • Figures & Tables
  • Related Content
  • Responses
  • Metrics
  • PDF

Related Articles

  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • A blistering variant of phlegmasia cerulea dolens from underlying squamous cell lung cancer
  • Parechovirus infections in infants
  • Radiation dermatitis in a patient treated for hepatocarcinoma
Show more Practice

Similar Articles

Collections

  • Article Types
    • Five Things to Know About
  • Topics
    • Interventional radiology
    • Pharmacology & toxicology

 

View Latest Classified Ads

Content

  • Current issue
  • Past issues
  • Collections
  • Sections
  • Blog
  • Podcasts
  • Alerts
  • RSS
  • Early releases

Information for

  • Advertisers
  • Authors
  • Reviewers
  • CMA Members
  • CPD credits
  • Media
  • Reprint requests
  • Subscribers

About

  • General Information
  • Journal staff
  • Editorial Board
  • Advisory Panels
  • Governance Council
  • Journal Oversight
  • Careers
  • Contact
  • Copyright and Permissions
  • Accessibiity
  • CMA Civility Standards
CMAJ Group

Copyright 2023, CMA Impact Inc. or its licensors. All rights reserved. ISSN 1488-2329 (e) 0820-3946 (p)

All editorial matter in CMAJ represents the opinions of the authors and not necessarily those of the Canadian Medical Association or its subsidiaries.

To receive any of these resources in an accessible format, please contact us at CMAJ Group, 500-1410 Blair Towers Place, Ottawa ON, K1J 9B9; p: 1-888-855-2555; e: cmajgroup@cmaj.ca

Powered by HighWire